MedPath

Dapaconazole

Generic Name
Dapaconazole
Drug Type
Small Molecule
Chemical Formula
C19H15Cl2F3N2O
CAS Number
1269726-67-1
Unique Ingredient Identifier
H2976538CX

Overview

Dapaconazole has been used in trials studying the treatment of Tinea Pedis.

Background

Dapaconazole has been used in trials studying the treatment of Tinea Pedis.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris
Phase 2
Completed
Posted: 2017/12/02
Sponsor:
Galeno Desenvolvimen...
ID:NCT03359070
Non-inferiority Trial of Dapaconazole Versus Ketoconazole
Phase 3
Completed
Posted: 2017/10/25
Sponsor:
Biolab Sanus Farmace...
ID:NCT03320486
Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis
Phase 2
Completed
Posted: 2016/07/07
Sponsor:
Gilberto De Nucci
ID:NCT02824926
Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis
Phase 3
Withdrawn
Posted: 2015/11/17
Sponsor:
Biolab Sanus Farmace...
ID:NCT02606383

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy